Kerry Stokes’ Media Executives and Their Interest in Orthocell
Seven West Media shows a strong interest in Orthocell, a lesser-known ASX-listed medtech company. Orthocell focuses on cell regeneration therapies and is based in Perth.
Background of Orthocell
The company was established in 2007, spun out of the University of Western Australia. Its market capitalization fluctuates around $300 million and has increased by about 80% over the past year.
Industry Context
Despite its growth, Orthocell remains one of many small medtech companies on the ASX, appealing mainly to specialized investors and observers.
“Most people wouldn’t have heard of Orthocell. It’s a Perth-based, ASX-listed medtech that makes cell regeneration therapies.”
Subscription Feature
Subscribers can gift five articles monthly to others, encouraging wider access to niche business insights about companies like Orthocell.
Author's summary: Orthocell, a small but rapidly growing ASX medtech company, draws attention from media executives despite its niche market presence and moderate profile.